Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
---|
04/22/2004 | US20040077617 for example 3-methylbicyclo[4.1.0]heptane-7-carboxylic acid or N-(2-amino-2-oxoethyl)-4,7,7-trimethyltricyclo [4.1.1.02,4]octane-3-carboxamide; use treating epilepsy, bipolar disorder, migraine, neuropathic and inflammatory pain |
04/22/2004 | US20040077600 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
04/22/2004 | US20040077021 Haptens, intermediates, and immunogens that are useful in the production of antibodies specific for the methylenedioxy class of amphetamine derivatives |
04/22/2004 | CA2501831A1 Activity-based probes, and methods of their preparation and use |
04/21/2004 | EP1408987A2 Tetracycline compounds having target therapeutic activities |
04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
04/21/2004 | CN1490307A Industrial production of benzofloxamide |
04/21/2004 | CN1490306A Carbon 13 labeled ledocaine and its salts preparations and uses |
04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |
04/15/2004 | WO2004006850A3 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
04/15/2004 | US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8 |
04/15/2004 | US20040072341 Bioactive oligopeptides |
04/15/2004 | US20040071851 Novel N-alkylaspartyl amide derivative and sweetening agent |
04/14/2004 | EP1406862A1 Substituted aminoalcohols useful in treatment of alzheimer's disease |
04/14/2004 | EP1406617A1 Diaminediols for the treatment of alzheimer's disease |
04/14/2004 | EP1406493A1 Administration of agents via the pept-2 transporter |
04/14/2004 | EP1286954B1 7-substituted fused ring tetracycline compounds |
04/14/2004 | EP1109781B1 Process to continuously prepare an aqueous mixture of epsilon-caprolactam and epsilon-caprolactam precursors |
04/14/2004 | EP1100772B1 Open chain alkoxyamine compounds and their use as polymerization regulators |
04/14/2004 | EP1073641B1 New substituted amides, their production and their use |
04/14/2004 | EP0724561B1 Calcium receptor-active arylalkyl amines |
04/14/2004 | CN1145608C Quanternary ammonium compounds as anti-tussive agents |
04/13/2004 | US6720452 Adamantane derivatives |
04/13/2004 | US6720169 By converting the corresponding acetal-protected aldehyde into the corresponding aminonitrile, converting the aminonitrile into the corresponding amino acid amide, and performing enzymatic, enantioselective hydrolysis |
04/13/2004 | US6719958 Polychelants, their complexes with metal ions, their preparation and their uses |
04/08/2004 | WO2004029018A1 Glycerol derivative |
04/08/2004 | WO2004016580A3 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
04/08/2004 | WO2002032856A9 Insecticidal 1,8-naphthalenedicarboxamides |
04/08/2004 | US20040068013 Supplying in situ using amino acid; immobilization |
04/08/2004 | US20040068007 Diclofenac salt of lidocaine |
04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
04/08/2004 | US20040067912 Microbiocides, antibiotic, antitumor agent |
04/08/2004 | US20040067525 Method for structural analysis of organic compound |
04/07/2004 | EP1405845A1 Method for purifying n2-(1(s)-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine |
04/07/2004 | EP1405646A2 Pharmaceutically acceptable salts of local anaesthetics with anti-inflammatory compounds and methods for preparing the same |
04/07/2004 | EP1404664A1 Aminediols for the treatment of alzheimer's disease |
04/07/2004 | EP1404328A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
04/07/2004 | EP1404322A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
04/07/2004 | EP1240132B1 Adamantane derivatives |
04/07/2004 | CN1486690A Medicinal salt with local narcosis and antiphlogosis activity and its prepn process |
04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
04/06/2004 | CA2190992C Naphthalene derivatives |
04/06/2004 | CA2075926C Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them |
04/03/2004 | CA2453071A1 Genes and proteins for the production of polyene polyketides |
04/01/2004 | WO2004026814A2 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
04/01/2004 | US20040063959 Esters and amides as PLA2 inhibitors |
04/01/2004 | US20040063904 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
04/01/2004 | US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders |
04/01/2004 | US20040063674 Tetracycline compounds having target therapeutic activities |
04/01/2004 | US20040062773 Compositions for the delivery of antigens |
04/01/2004 | CA2498759A1 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
03/31/2004 | EP1403247A1 N-Alkanoylphenylalanine derivatives |
03/31/2004 | EP0770065B1 Tri-substituted phenyl derivates useful as pde iv inhibitors |
03/31/2004 | CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
03/31/2004 | CN1486298A Prodrugs of excitatory amino acids |
03/30/2004 | US6713650 ABCA-1 elevating compounds |
03/30/2004 | US6713635 As chemical intermediates used for the preparation of s-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
03/30/2004 | US6713517 Using n-(2-diethylamino-ethyl)-4-amino-3-chlorobenzamide |
03/30/2004 | US6713514 Such as 2-(benzylamino)-3-(4-(n-(3-phenylpropyl)carbamoyl)-phenyl)propanoic acid |
03/25/2004 | WO2004024755A2 Sarcolysyl derivatives and method for the production thereof |
03/25/2004 | WO2004024675A1 Substituted aminoethers for the treatment of alzheimer's disease |
03/25/2004 | WO2003072528A3 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
03/25/2004 | WO2003057721A3 Substituted amino carboxamides for the treatment of alzheimer's disease |
03/25/2004 | WO2003048106A3 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
03/25/2004 | WO2002088085A3 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
03/25/2004 | US20040059149 Method for the synthesis of compounds of formula 1 and derivatives thereof |
03/25/2004 | US20040058991 Anticonvulsants; central nervous system disorders |
03/25/2004 | US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
03/25/2004 | CA2498269A1 Substituted aminoethers for the treatment of alzheimer's disease |
03/24/2004 | EP1399414A2 Substituted tetracycline compounds for the treatment of malaria |
03/24/2004 | EP0784469B1 Compositions for the delivery of antigens |
03/24/2004 | CN1483723A Method for purifying ioversol |
03/24/2004 | CN1142907C Process to continuously prepare aqueous mixture of epsi-caprolacta and epsi caprolactam precursors |
03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
03/20/2004 | CA2406504A1 Method of treating resistant tumors |
03/18/2004 | WO2004022541A1 1,4-substituted cyclohexane derivatives |
03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
03/18/2004 | WO2003099763A8 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
03/18/2004 | WO2003097576A3 Diamino-functional chalcones |
03/18/2004 | WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
03/18/2004 | US20040054186 Autoimmune diseases; anticancer agents; antiproliferative agents; skin disorders |
03/18/2004 | US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
03/18/2004 | US20040053907 Cell adhesion inhibitors |
03/18/2004 | US20040053786 Insecticidal 1,8-naphthalenedicarboxamides |
03/18/2004 | DE10239832A1 New sarcolysine derivatives, e.g. amide or peptide compounds, useful as anticancer agents with reduced toxicity to healthy cells |
03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
03/17/2004 | EP1397370A1 B-benzyloxyaspartate derivatives with amino group on benzene ring |
03/17/2004 | EP1242364B1 Adamantane derivatives |
03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
03/17/2004 | EP1003558B1 Lipid-polyamide conjugates and compositions for nucleic acid delivery |
03/17/2004 | EP0998488B1 Polyol-amino acid compounds having anti-helicobacter pylori activity |